GTSDX
Price
$7.71
Change
+$0.16 (+2.12%)
Updated
Apr 23 closing price
Net Assets
1.55B
VEXRX
Price
$94.76
Change
+$2.20 (+2.38%)
Updated
Apr 24 closing price
Net Assets
19.79B
Ad is loading...

GTSDX vs VEXRX

Header iconGTSDX vs VEXRX Comparison
Open Charts GTSDX vs VEXRXBanner chart's image
Invesco Small Cap Growth C
Price$7.71
Change+$0.16 (+2.12%)
VolumeN/A
Net Assets1.55B
Vanguard Explorer Adm
Price$94.76
Change+$2.20 (+2.38%)
VolumeN/A
Net Assets19.79B
GTSDX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GTSDX vs. VEXRX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTSDX is a Buy and VEXRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. GTSDX (1.55B). VEXRX pays higher dividends than GTSDX: VEXRX (0.56) vs GTSDX (0.00). GTSDX was incepted earlier than VEXRX: GTSDX (26 years) vs VEXRX (23 years). GTSDX (1.87) is less costly to investors than VEXRX (0.34). GTSDX is a more actively managed with annual turnover of: 55.00 vs. VEXRX (35.00). GTSDX has a lower initial minimum investment than VEXRX: GTSDX (1000) vs VEXRX (50000). GTSDX annual gain was more profitable for investors over the last year : -8.71 vs. VEXRX (-12.82). VEXRX return over 5 years is better than : 15.80 vs. GTSDX (-59.45).
GTSDXVEXRXGTSDX / VEXRX
Total Expense Ratio1.870.34550%
Annual Report Gross Expense Ratio1.870.34550%
Fund Existence26 years23 years-
Gain YTD-17.576-14.722119%
Front LoadN/AN/A-
Min. Initial Investment1000500002%
Min. Initial Investment IRAN/AN/A-
Net Assets1.55B19.8B8%
Annual Yield % from dividends0.000.56-
Returns for 1 year-8.71-12.8268%
Returns for 3 years-15.36-9.40163%
Returns for 5 years-59.4515.80-376%
Returns for 10 years-74.71-1.764,236%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XBI79.101.46
+1.88%
SPDR® S&P Biotech ETF
CHI9.780.17
+1.77%
Calamos Convertible Opportunities and Income Fund
SBIO28.020.45
+1.63%
ALPS Medical Breakthroughs ETF
BCDF28.540.12
+0.44%
Horizon Kinetics Blockchain Dev ETF
FEP41.67-0.06
-0.14%
First Trust Europe AlphaDEX® ETF